Metastatic Breast Cancer in Bones: Treatment and Survival

Breast cancer commonly spreads to distant parts of the body, with bones being the most frequent site of metastasis, affecting up to 75% of metastatic breast cancer patients1 2. This spread disrupts normal bone function and can cause significant symptoms and complications. Although metastatic breast cancer in bones is currently incurable, advances in treatment have improved symptom management and extended survival for many patients3 1.

Causes of Breast Cancer Metastasis

Metastatic breast cancer occurs when cancer cells migrate from the primary tumor in the breast to distant organs, including bones3 . These cancer cells disseminate primarily through the bloodstream, allowing them to reach and colonize the bone marrow1 . Once in the bone, cancer cells disrupt the normal bone remodeling process by stimulating osteoclasts, the cells responsible for bone breakdown, leading to bone destruction and skeletal complications1 4.

The specific mechanisms that govern why breast cancer cells preferentially metastasize to bone are not fully understood, but several factors contribute:

Hormone receptor-positive breast cancers, especially those expressing estrogen receptors, have a higher tendency to metastasize to bone due to interactions with the bone microenvironment3 1.
The spine is the most common site for bone metastases, followed by ribs, pelvis, and long bones of the arms and legs4 5.
Failure to respond to initial therapy or delayed treatment can increase the risk of metastatic spread to bone3 .

Recent research has identified molecular drivers of bone metastasis, such as acyl-CoA binding protein (ACBP), which regulates lipid metabolism in metastatic cells and supports their survival in bone tissue. Targeting such pathways may offer new therapeutic options in the future6 .

Symptoms of Bone Metastases from Breast Cancer

Bone metastases often cause symptoms that can significantly affect quality of life. The most common and earliest symptom is new or progressive bone pain, which may be described as gnawing or persistent and can worsen at rest or during the night7 5. This pain can be mistaken for arthritis or other musculoskeletal conditions, so prompt evaluation is important.

Other symptoms and signs include:

Fragile or weakened bones leading to pathological fractures, which occur more easily than normal fractures due to cancer-induced bone weakening8 .
Swelling or lumps near lymph nodes, which may indicate recurrence but are not specific to bone metastases1 .
Systemic symptoms such as unexplained weight loss, fatigue, and loss of appetite7 .
Neurological symptoms like numbness, weakness, or difficulty controlling bladder or bowel function, which may indicate spinal cord compression from vertebral metastases5 .

Early recognition of these symptoms is critical for timely diagnosis and management to prevent serious complications.

Treatment Options for Bone Metastases

Treatment of bone metastases in breast cancer aims to control tumor growth, relieve symptoms, prevent skeletal-related events (SREs), and improve quality of life. Although metastatic bone disease is incurable, a multidisciplinary approach combining systemic and local therapies is standard3 1.

Chemotherapy and Immunotherapy: These systemic treatments target cancer cells throughout the body and are used depending on cancer subtype and progression3 9.
Hormone Therapy: Effective for hormone receptor-positive metastatic breast cancer, hormone therapies reduce estrogen effects that promote cancer growth3 9.
Targeted Therapies: Drugs that interfere with specific cancer cell processes, including CDK4/6 inhibitors and HER2-targeted agents, are used based on tumor characteristics9 .
Bisphosphonates (e.g., zoledronic acid): These drugs inhibit osteoclast-mediated bone resorption, strengthening bones and reducing fracture risk3 10.
Denosumab: A monoclonal antibody that also inhibits osteoclast activity, denosumab reduces skeletal complications and is administered via subcutaneous injection3 11.

Both classes of drugs help prevent SREs such as fractures and spinal cord compression and are often given monthly or every 12 weeks depending on patient response11 .

Radiation therapy is effective in reducing bone pain, controlling local tumor growth, and stabilizing weakened bones. Techniques include:

External Beam Radiation Therapy: Commonly used for pain relief and prevention of fractures3 2.
Stereotactic Body Radiation Therapy (SBRT): Delivers high-dose radiation precisely to bone lesions, minimizing damage to surrounding tissue5 .

Surgical options are considered for bones at high risk of fracture or after a fracture has occurred. Procedures include:

Stabilization with rods, pins, or plates to support weakened bones8 5.
Vertebroplasty and kyphoplasty, which involve injecting bone cement into vertebrae to relieve pain and strengthen the spine11 5.

Surgery may also be used to decompress the spinal cord if compression occurs11 .

Experimental drugs like RK-33, which targets the DDX3 protein involved in cancer cell growth, have shown promise in preclinical models by eliminating bone metastases and preventing their spread12 .

Pain control is a key component of treatment, often involving analgesics, radiotherapy, and bone-strengthening agents. Managing hypercalcemia (high calcium levels due to bone breakdown) and preventing fractures are also critical3 5.

“Treatment can often shrink tumors or slow their growth, improve symptoms, and help some women live longer.”
— American Cancer Society9

Life Expectancy and Prognosis

Bone metastases indicate advanced breast cancer and are associated with a poorer prognosis compared to early-stage disease3 . However, survival varies widely depending on factors such as the extent of metastasis, cancer subtype, and treatment response.

Bone metastases occur in approximately 65%–75% of metastatic breast cancer cases1 2.
Patients with bone-only metastases generally have better survival than those with visceral (organ) or brain metastases7 .
The three-year overall survival (OS) rate for bone metastases is about 50.5%, higher than liver (38.2%), lung (37.5%), or brain metastases (19.9%) 7.
One-year survival for bone metastases is approximately 51%, while five-year survival may be as low as 13% in some cohorts7 .
The overall five-year relative survival rate for stage 4 breast cancer is around 29% 313.

Survival outcomes are influenced by:

Age and general health13 .
Cancer subtype, with hormone receptor-positive cancers showing better prognosis3 1.
Number and location of metastases; solitary bone lesions have improved prognosis compared to multiple lesions14 .
Advances in systemic therapies have improved life expectancy and quality of life for many patients1 9.

Summary and Key Points

Metastatic breast cancer in bones significantly impacts quality of life but can be managed effectively with current treatments. Advances in systemic and targeted therapies have extended survival and improved symptom control for many patients1 39.

Metastatic breast cancer in bones is a common and serious condition that disrupts normal bone function and causes significant symptoms. While incurable, it is manageable with a combination of systemic therapies, bone-modifying agents, radiotherapy, and surgery. Early recognition of symptoms such as new bone pain and fractures is essential for timely treatment.

Breast cancer cells spread to bone via the bloodstream and disrupt bone remodeling, leading to skeletal complications3 1.
Bone metastases cause pain, fractures, and neurological symptoms, requiring prompt medical evaluation7 5.
Treatment focuses on slowing cancer progression, relieving symptoms, and preventing fractures using chemotherapy, hormone therapy, bone-strengthening drugs, radiotherapy, and surgery3 8.
Survival rates vary by metastatic site, with bone-only metastases associated with better outcomes than visceral or brain metastases7 .
Ongoing research into novel therapies targeting molecular drivers of bone metastasis offers hope for improved future treatments12 6.